Spironolactone
Product Images NDC 67296-1692

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 67296-1692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epm 30 Count (67296 1692 3)

This is a description of a medication: Spironolactone 25mg tablets manufactured by Cadila Healthcare LTD in Baddi, India. The NDC number is 67296-1692-3 and the product contains 30 tablets, with an expiration date of 11/20 and lot number 8D4647X1. The drug is distributed by Redpharm Drug, located in Eden Prairie, MN. The recommended storage temperature is 2025 C (68-77 F). Adult dosage information is available in the package insert.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 01)

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)

The text is presenting results of a study or trial involving the use of Spironolactone and Placebo in two different groups represented by n=822 and n=841. The study involved monitoring the groups for up to 42 months as represented on the timeline. The results of the study were significant with a log-rank p<0.001. No further information is available from the given text.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)

This is a table showing the various subgroups of a study related to heart failure. The subgroups are based on age, sex, race, LVEF (%), NYHA, Diabetes, Serum creatinine (mg/dL), CrClearance (mLimin/1.73 sqm), Potassium (mmoilL), Digoxin, ACE, and Beta Blocker. The table also includes the number of participants in each subgroup along with their HR (Heart Rate) and 95% CI (Confidence Interval) N (Sample Size) values. Finally, there is a comparison of the effectiveness of Spironolactone and Placebo.*

FDA Label Image

Image4 (B9a028ee 5720 4b9e A625 F7130aafd084 04)

NDC number 68382-660-01 belongs to a Spironolactone drug in tablet form. Each tablet is film-coated and contains 25mg of Spironolactone, a medication used for treating various heart, liver, and kidney-related health conditions. The ideal dosage is mentioned in the package insert. It should be stored at room temperature and protected from light. This drug should be kept out of children's reach. It is manufactured in Baddi, India, by the Cadia Healthcare Ltd., and distributed by Zydus Pharmaceuticals (USA) Inc. located in Pennington, NJ.*

FDA Label Image

Image5 (B9a028ee 5720 4b9e A625 F7130aafd084 05)

This is a description of a medication called Spironolactone which comes in the form of tablets. Each film coated tablet contains 50 mg of Spironolactone, USP for prescribed use. The packaging and usage instructions are provided in the package insert. The medication should be stored at room temperature and protected from light. It should be dispensed in a tight, light-resistant container to ensure quality. This drug should be kept out of reach of children. The drug is manufactured by Cadila Healthcare Ltd. in Badd, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

FDA Label Image

Image6 (B9a028ee 5720 4b9e A625 F7130aafd084 06)

NDC 68382-662-01 is a prescription drug called Spironolactone that comes in the form of tablets. Each film-coated tablet contains 100 mg of spironolactone, USP. The package insert should be consulted for complete prescribing information, including usual dosage. It should be stored in a light-resistant container within the USP controlled room temperature of 20° to 25°C (68° to 77°F). Manufactured by Cadia Healthcare Ltd. in Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534. It is advised to keep this and all drugs out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.